Prnewswire·2025-09-26 12:30Core Insights - Alexandria Real Estate Equities, Inc. has announced the opening of Lilly Gateway Labs in San Diego, enhancing its collaborative Megacampus ecosystem aimed at biotechnology innovation [1][2][3] Company Overview - Alexandria Real Estate Equities, Inc. is a leading life science real estate investment trust (REIT) with a market capitalization of $25.7 billion and an asset base that includes 39.7 million RSF of operating properties and 4.4 million RSF of Class A/A+ properties under construction [5][6] Strategic Collaboration - The Lilly Gateway Labs operates in collaboration with Eli Lilly and Company, integrating Alexandria's real estate infrastructure with Lilly's scientific expertise and venture network [2][3] - This partnership aims to accelerate the development of early-stage biotech companies and foster collaboration between innovative biotechs and large pharmaceutical firms [3] Facility Features - The new Lilly Gateway Labs is located in a LEED Gold certified all-electric laboratory facility, featuring modular lab spaces, advanced scientific tools, and operational support services [4] - The facility is designed to support a diverse range of biotech companies focusing on various disease areas, including Alzheimer's, Parkinson's, cardiovascular diseases, and oncology [4] Ecosystem Development - Alexandria has been instrumental in developing the San Diego life science ecosystem since 1994, positioning the One Alexandria Square Megacampus as a hub for innovation and collaboration [3] - The Megacampus includes amenities such as a café, restaurant, event lawn, and proximity to renowned research institutions, enhancing the ability of tenants to attract and retain talent [3]